Home > Insider Trading > Filing (0001181431-11-026973)

Filing Details

Accession Number:: 0001181431-11-026973
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-05-03 21:29:53
Reporting Period:: 2011-05-03

Filing Date:: 2011-05-03
Accepted Time:: 2011-05-03 21:29:53
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1326104	Jeffrey David Medeiros	1300 North Kellogg Drive Suite D Anaheim CA 92807	Senior Vp, Pharm. Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-04-29	4,841	$0.60	507,946	No	4	M	Direct
Common Stock	Acquisiton	2011-04-29	200,000	$1.02	707,946	No	4	M	Direct
Common Stock	Disposition	2011-04-29	204,841	$20.36	503,105	No	4	S	Direct
Common Stock	Disposition	2011-05-02	80,372	$20.70	422,733	No	4	S	Direct
Common Stock	Disposition	2011-05-03	4,500	$20.38	418,233	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-04-29	4,841	$0.00	4,841	$0.60
Common Stock	Stock Option (Right to Buy)	Disposition	2011-04-29	200,000	$0.00	200,000	$1.02

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2013-12-10	No	4	M	Direct
0		2013-06-08	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.32-$20.501, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.46-$21.065, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 2 of the Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.38-$20.39, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 3 of the Form 4.
Incentive Stock option granted under the Questcor Pharmaceuticals, Inc. 1992 Employee Stock Option Plan on December 11, 2003.
Incentive Stock option granted under the Questcor Pharmaceuticals, Inc. 1992 Employee Stock Option Plan on June 9, 2003.
The option was fully vested and exercisable as of December 11, 2007.
25,000 shares of the option were fully vested and exercisable as of December 9, 2003 and 175,000 were fully vested and exercisable as of June 9, 2007.